Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
FDA removed black box warning on menopausal hormone therapy, but experts caution against unnecessary, costly hormone tests.
The FDA removed a black box warning on menopausal hormone therapy, highlighting benefits like reduced bone fractures and cognitive decline, sparking renewed interest.
However, experts warn that hormone testing—especially at-home or broad panels costing up to $1,000—is often unnecessary and misleading, as hormone levels naturally fluctuate during perimenopause.
Doctors stress that symptoms like hot flashes, mood swings, and sleep issues should guide treatment, not test results.
Despite rapid growth in the U.S. endocrine testing market, medical professionals caution against "meno-profiteering" and recommend consulting a healthcare provider before pursuing expensive or unproven tests or supplements.
La FDA eliminó la advertencia de la caja negra sobre la terapia hormonal menopáusica, pero los expertos advierten contra las pruebas de hormonas innecesarias y costosas.